Evotec and Takeda enter collaboration agreement to discover clinical candidates across multiple therapeutic areas Read more
NeuCyte Licenses Promising Novel Compound for Treatment of Refractory Epilepsy and Related Neurological Disorders Read more
Catalent And Minerva Neurosciences Enter Commercial Supply Agreement For Schizophrenia Drug Roluperidone Read more
I-Mab Biopharma Announces Clinical Collaboration to Evaluate TJC4 in Combination with KEYTRUDA (pembrolizumab) Read more
Clovis Oncology Acquires Rights to FAP-Targeted Radiopharmaceutical Program from 3B Pharmaceuticals Read more